InvestorsObserver
×
News Home

Where Does CureVac BV (CVAC) Stock Fall in the Biotechnology Field After It Is Up 1.31% This Week?

Tuesday, October 19, 2021 02:46 PM | InvestorsObserver Analysts

Mentioned in this article

Where Does CureVac BV (CVAC) Stock Fall in the Biotechnology Field After It Is Up 1.31% This Week?

A rating of 13 puts CureVac BV (CVAC) near the bottom of the Biotechnology industry according to InvestorsObserver. CureVac BV's score of 13 means it scores higher than 13% of stocks in the industry. CureVac BV also received an overall rating of 24, putting it above 24% of all stocks. Biotechnology is ranked 87 out of the 148 industries.

Overall Score - 24
CVAC has an Overall Score of 24. Find out what this means to you and get the rest of the rankings on CVAC!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With CureVac BV Stock Today?

CureVac BV (CVAC) stock is trading at $41.72 as of 2:44 PM on Tuesday, Oct 19, a gain of $0.74, or 1.81% from the previous closing price of $40.98. The stock has traded between $40.71 and $42.72 so far today. Volume today is low. So far 359,501 shares have traded compared to average volume of 706,022 shares. Click Here to get the full Stock Report for CureVac BV stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App